-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Downgrades enGene Therapeutics to Market Perform

Benzinga·05/08/2026 14:46:11
Listen to the news
Citizens analyst Silvan Turkcan downgrades enGene Therapeutics (NASDAQ:ENGN) from Market Outperform to Market Perform.